Search results

Filters

  • Journals
  • Authors
  • Keywords
  • Date
  • Type

Search results

Number of results: 5
items per page: 25 50 75
Sort by:
Download PDF Download RIS Download Bibtex

Abstract

With the development of the society in recent years, there are more and more housing construction areas. The traditional concrete has not been able to satisfy the demand of housing construction. In this study, prefabricated concrete was applied in the design of assembling style houses considering their characteristics, and its economic, environmental and social benefits were analyzed combining risk matrix evaluation method and management strategy. It was found that the use of prefabricated concrete as a building material could effectively shorten the construction period, reduce the construction cost and improve the construction safety, playing a role of energy saving and environmental protection. Therefore it was concluded that prefabricated concrete can improve the efficiency of construction, reduce environmental pollution and save energy. This work provides a reference for the application of prefabricated concrete in residential buildings and its safety management.

Go to article

Authors and Affiliations

L. Jiao
X.D. Li
Download PDF Download RIS Download Bibtex

Abstract

Osteocalcin is a major non-collagenous component of the bone extracellular matrix and is considered to be an indicative factor of osteoblast differentiation. In the present study, we detected osteocalcin expression in different antler areas and growth phases by immunohisto- chemistry. Osteocalcin was highly expressed in all areas during the mineralization period and in mesenchymal cell and chondrocyte areas during the rapid growth period. The nucleotide sequence of the osteocalcin gene in sika deer antler was determined. The open reading frame was 303 bp encoding a protein of 100 amino acids. The estimated molecular mass of osteocalcin was 10.38 kDa and the theoretical isoelectric point was 5.37. The osteocalcin gene with a 6× His-tag at the C-terminus was cloned into the pGEX-4T1 vector and expressed in Escherichia coli under optimal conditions. The recombinant soluble protein fused with GST was purified with Ni-NTA resin. The purified osteocalcin protein exhibited a significant increase in HA adhesion and promoted antler chondrocyte proliferation. Osteocalcin is an important factor in regulating the rapid growth and differentiation of deer antlers.

Go to article

Authors and Affiliations

X. Li
M. Liu
X. Bai
Y. Li
Y. Zhao
S. Wang
J. Wang
Download PDF Download RIS Download Bibtex

Abstract

Porcine parvovirus (PPV) is a major causative agent in reproductive pig disease. The swine industry faces a significant economic and epizootic threat; thus, finding a reliable, quick, and practical way to detect it is essential. In this investigation, recombinant PPV VP2 protein was expressed in the Escherichia coli ( E. coli) expression systems. As shown by electron microscopy (TEM), Western blot, and hemagglutination (HA) assays, the recombinant VP2 protein was successfully assembled into virus-like particles (VLPs) after being expressed and purified. These VLPs had a structure that was similar to that of real PPV viruses and also exhibited HA activity. These VLPs induced high levels of PPV-specific antibody titers in mice after immunization, indicating that the VLPs may be beneficial as potential candidate antigens. VLPs were used as the coating antigens for the VLP ELISA, and the PPV VLPs-based ELISA displayed a high sensitivity (99%), specificity (93.0%) and agreement rate (98.3%) compared to HI assay, and the agreement rate of this ELISA was 97.5% compared to a commercial ELISA kit. Within a plate, the coefficient of variation (CV) was 10%, and between ELISA plates, the CV was 15%. According to a cross-reactivity assay, the technique was PPV-specific in contrast to other viral illness sera. The PPV VLP indirect-ELISA test for PPV detection in pigs with an inactivated vaccine showed that the PPV-positive rate varied among different sample sources from 88.2 to 89.6%. Our results indicate that this ELISA technique was quick, accurate, and repeatable and may be used for extensive serological research on PPV antibodies in pigs.
Go to article

Bibliography

1. Allan GM, Kennedy S, McNeilly F, Foster JC, Ellis JA, Krakowka SJ, Meehan BM, Adair BM (1999) Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J Comp Pathol 121(1): 1-11.
2. Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B (2005) Cloning of a human parvovirus by molecu-lar screening of respiratory tract samples. Proc Natl Acad Sci U S A 102(36): 12891-12896.
3. Cartwright SF, Lucas M, Huck RA (1971) A small haemaggultinating porcine DNA virus. II. Biological and serological studies. J Comp Pathol 81(1): 145-155.
4. Choi C, Chae C (2000) Distribution of porcine parvovirus in porcine circovirus 2-infected pigs with postweaning multisystemic wasting syndrome as shown by in-situ hybridization. J Comp Pathol 123(4): 302-305.
5. Crowther JR (2000) The ELISA guidebook. Methods Mol Biol 149: III-IV, 1-413.
6. Ellis JA, Bratanich A, Clark EG, Allan G, Meehan B, Haines DM, Harding J, West KH, Krakowka S, Konoby C, Hassard L, Martin K, McNeilly F (2000) Coinfection by porcine circoviruses and porcine parvovirus in pigs with naturally acquired postweaning multisystem-ic wasting syndrome. J Vet Diagn Invest 12(1): 21-27.
7. Feng H, Hu GQ, Wang HL, Liang M, Liang H, Guo H, Zhao P, Yang YJ, Zheng XX, Zhang ZF, Zhao YK, Gao YW, Yang ST, Xia XZ (2014) Canine parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenic-ity. PLoS One 9(1): e79575.
8. Hohdatsu T, Baba K, Ide S, Tsuchimoto M, Nagano H, Yamagami T, Yamagishi H, Fujisaki Y, Matumoto M (1988) Detection of anti-bodies against porcine parvovirus in swine sera by enzyme-linked immunosorbent assay. Vet Microbiol 17(1): 11-19.
9. Hua T, Zhang D, Tang B, Chang C, Liu G, Zhang X (2020) The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus. Vet Microbiol 248: 108795.
10. Jenkins CE (1992) An enzyme-linked immunosorbent assay for detection of porcine parvovirus in fetal tissues. J Virol Methods 39(1-2): 179-184.
11. Ji P, Liu Y, Chen Y, Wang A, Jiang D, Zhao B, Wang J, Chai S, Zhou E, Zhang G (2017) Porcine parvovirus capsid protein expressed in Escherichia coli self-assembles into virus-like particles with high immunogenicity in mice and guinea pigs. Antiviral Res 139: 146-152.
12. Joo HS, Donaldson-Wood CR, Johnson RH (1976) A standardised haemagglutination inhibition test for porcine parvovirus antibody. Aust Vet J 52(9): 422-424.
13. Jozwik A, Manteufel J, Selbitz HJ, Truyen U (2009) Vaccination against porcine parvovirus protects against disease, but does not pre-vent infection and virus shedding after challenge infection with a heterologous virus strain. J Gen Virol 90(Pt 10): 2437-2441.
14. Kennedy S, Moffett D, McNeilly F, Meehan B, Ellis J, Krakowka S, Allan GM (2000) Reproduction of lesions of postweaning multi-systemic wasting syndrome by infection of conventional pigs with porcine circovirus type 2 alone or in combination with porcine parvo-virus. J Comp Pathol 122(1): 9-24.
15. Kong M, Peng Y, Cui Y, Chang T, Wang X, Liu Z, Liu Y, Zhu Y, Luo Y, Tang Q, Feng L, Cui S (2014) Development and evaluation of the rVP-ELISA for detection of antibodies against porcine parvovirus. J Virol Methods 206: 115-118.
16. Marcekova Z, Psikal I, Kosinova E, Benada O, Sebo P, Bumba L (2009) Heterologous expression of full-length capsid protein of por-cine circovirus 2 in Escherichia coli and its potential use for detection of antibodies. J Virol Methods 162(1-2): 133-141.
17. Mengeling WL, Cutlip RC (1976) Reproductive disease experimentally induced by exposing pregnant gilts to porcine parvovirus. Am J Vet Res 37(12): 1393-1400.
18. Mengeling WL, Lager KM, Vorwald AC (2000) The effect of porcine parvovirus and porcine reproductive and respiratory syndrome vi-rus on porcine reproductive performance. Anim Reprod Sci 60-61: 199-210.
19. Meszaros I, Olasz F, Csagola A, Tijssen P, Zadori Z (2017) Biology of porcine parvovirus (Ungulate parvovirus 1). Viruses 9(12): 393.
20. Oravainen J, Hakala M, Rautiainen E, Veijalainen P, Heinonen M, Tast A, Virolainen JV, Peltoniemi OA (2006) Parvovirus antibodies in vaccinated gilts in field conditions-results with HI and ELISA tests. Reprod Domest Anim 41(1): 91-93.
21. Oravainen J, Heinonen M, Tast A, Virolainen J, Peltoniemi O (2005) High porcine parvovirus antibodies in sow herds: prevalence and associated factors. Reprod Domest Anim 40(1): 57-61.
22. Qing L, Lv J, Li H, Tan Y, Hao H, Chen Z, Zhao J, Chen H (2006) The recombinant nonstructural polyprotein NS1 of porcine parvovi-rus (PPV) as diagnostic antigen in ELISA to differentiate infected from vaccinated pigs. Vet Res Commun 30(2): 175-190.
23. Roic B, Cajavec S, Toncic J, Madic J, Lipej Z, Jemersic L, Lojkic M, Mihaljevic Z, Cac Z, Sostaric B (2005) Prevalence of antibodies to porcine parvovirus in wild boars (Sus scrofa) in Croatia. J Wildl Dis 41(4): 796-799.
24. Shang SB, Li YF, Guo JQ, Wang ZT, Chen QX, Shen HG, Zhou JY (2008) Development and validation of a recombinant capsid pro-tein-based ELISA for detection of antibody to porcine circovirus type 2. Res Vet Sci 84(1): 150-157.
25. Streck AF, Canal CW, Truyen U (2015) Molecular epidemiology and evolution of porcine parvoviruses. Infect Genet Evol 36: 300-306.
26. Westenbrink F, Veldhuis MA, Brinkhof JM (1989) An enzyme-linked immunosorbent assay for detection of antibodies to porcine par-vovirus. J Virol Methods 23(2): 169-178.
27. Xu Y, Li Y (2007) Induction of immune responses in mice after intragastric administration of Lactobacillus casei producing porcine par-vovirus VP2 protein. Appl Environ Microbiol 73(21): 7041-7047.
28. Zeeuw EJL, Leinecker N, Herwig V, Selbitz HJ, Truyen U (2007) Study of the virulence and cross-neutralization capability of recent porcine parvovirus field isolates and vaccine viruses in experimentally infected pregnant gilts. J Gen Virol 88(Pt 2): 420-427.
29. Zheng HH, Wang LQ, Fu PF, Zheng LL, Chen HY, Liu F (2020) Characterization of a recombinant pseudorabies virus expressing por-cine parvovirus VP2 protein and porcine IL-6. Virol J 17(1): 19.
Go to article

Authors and Affiliations

Y. Li
1
Q. Wang
2
W. Yue
1
X. Li
1
Y. Chen
1
Y. Gao
1

  1. Beijing Biomedicine Technology Center of JoFunHwa Biotechnology (Nanjing Co. Ltd.); No.25 Xiangrui Street Daxing District, Beijing 102600 China
  2. State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150001, China
Download PDF Download RIS Download Bibtex

Abstract

Airway remodeling is a major pathological characteristic of chronic obstructive pulmonary disease (COPD). This study aimed to investigate the effect of Abhd2 deficiency on ovalbumin (OVA)-induced airway remodeling and inflammation in vivo. Abhd2-deficient mice were used to establish an OVA-induced asthma model. Lung tissues were analyzed using hematoxylin and eosin (HE) staining, Masson staining, immunohistochemistry, quantitative reverse transcription- polymerase chain reaction (qRT-PCR), and western blotting were used to determine the role of Abhd2 in the regulation of OVA-induced airway remodeling and inflammation. Our findings revealed that the RNA expression of inflammatory factors, including IL-1β, IL-6, IL-4, and IL-13, was significantly increased in OVA-induced Abhd2 Gt/Gt asthmatic mice. The expression of IFN-γ was decreased significantly in OVA-induced Abhd2 Gt/Gt asthmatic mice. The protein expression of airway remodeling factors, including α-SMA, type I collagen, and Ki67, was also increased in OVA-induced Abhd2 Gt/Gt asthmatic mice compared to that in OVA-induced wild-type (WT) mice. Additionally, Abhd2 deficiency promoted the expression of p-Akt in tissues of the asthma model. These results suggest that Abhd2 deficiency exacerbates airway remodeling and inflammation through the PI3K/Akt pathway in chronic asthma.
Go to article

Bibliography

1. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, Nair H, Gasevic D, Sridhar D, Campbell H, Chan KY, Sheikh A, Rudan I, Global Health Epidemiology Reference G (2015) Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health 5: 020415.
2. Barnes PJ (2016) Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 138: 16-27.
3. Barnes PJ, Burney PG, Silverman EK, Celli BR, Vestbo J, Wedzicha JA, Wouters EF (2015) Chronic obstructive pulmonary disease. Nat Rev Dis Primers 1: 15076.
4. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald JM, Gibson P, Ohta K, O’Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31: 143-178.
5. Bodas M, Moore AR, Subramaniyan B, Georgescu C, Wren JD, Freeman WM, Brown BR, Metcalf JP, Walters MS (2021) Cigarette Smoke Activates NOTCH3 to Promote Goblet Cell Differentiation in Human Airway Epithelial Cells. Am J Respir Cell Mol Biol 64: 426-440.
6. Boulet LP (2018) Airway remodeling in asthma: update on mechanisms and therapeutic approaches. Curr Opin Pulm Med 24: 56-62.
7. Damera G, Tliba O, Panettieri RA Jr. (2009) Airway smooth muscle as an immunomodulatory cell. Pulm Pharmacol Ther 22: 353-359.
8. Evasovic JM, Singer CA (2019) Regulation of IL-17A and implications for TGF-beta1 comodulation of airway smooth muscle remod-eling in severe asthma. Am J Physiol Lung Cell Mol Physiol 316: L843-L868.
9. Gueders MM, Foidart JM, Noel A, Cataldo DD (2006) Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respir-atory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 533: 133-144.
10. Gutor SS, Richmond BW, Du RH, Wu P, Lee JW, Ware LB, Shaver CM, Novitskiy SV, Johnson JE, Newman JH, Rennard SI, Miller RF, Blackwell TS, Polosukhin VV (2022) Characterization of Immunopathology and Small Airway Remodeling in Constrictive Bron-chiolitis. Am J Respir Crit Care Med 206: 260-270.
11. Hartley RA, Barker BL, Newby C, Pakkal M, Baldi S, Kajekar R, Kay R, Laurencin M, Marshall RP, Sousa AR, Parmar H, Siddiqui S, Gupta S, Brightling CE (2016) Relationship between lung function and quantitative computed tomographic parameters of airway remod-eling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: A single-center study. J Allergy Clin Immunol 137: 1413-1422.
12. He Y, Yang Y, Liao Y, Xu J, Liu L, Li C, Xiong X (2020) miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2. Mol Ther Oncolytics 17: 83-93.
13. Hinks TS, Levine SJ, Brusselle GG (2021) Treatment options in type-2 low asthma. Eur Respir J 57:2000528.
14. Jia Z, Bao K, Wei P, Yu X, Zhang Y, Wang X, Wang X, Yao L, Li L, Wu P, Yuan W, Wang S, Zheng J, Hua Y, Hong M (2021) EGFR activation-induced decreases in claudin1 promote MUC5AC expression and exacerbate asthma in mice. Mucosal Immunol 14: 125-134.
15. Jin S, Zhao G, Li Z, Nishimoto Y, Isohama Y, Shen J, Ito T, Takeya M, Araki K, He P, Yamamura K (2009) Age-related pulmonary emphysema in mice lacking alpha/beta hydrolase domain containing 2 gene. Biochem Biophys Res Commun 380: 419-424.
16. Joyce NC, Meklir B, Joyce SJ, Zieske JD (1996) Cell cycle protein expression and proliferative status in human corneal cells. Invest Ophthalmol Vis Sci 37: 645-655.
17. Kumar MN, Thunuguntla VB, Veeramachaneni GK, Sekhar BC, Guntupalli S, Bondili JS (2016) Molecular characterization of human ABHD2 as TAG lipase and ester hydrolase. Bioscience Reports 36:e00358.
18. Lanng MB, Moller CB, Andersen AH, Palsdottir AA, Roge R, Ostergaard LR, Jorgensen AS (2019) Quality assessment of Ki67 stain-ing using cell line proliferation index and stain intensity features. Cytometry A 95: 381-388.
19. Li H, Li J, Lu T, Chen D, Xu R, Sun W, Luo X, Li H, Ma R, Wen W (2021) DZNep attenuates allergic airway inflammation in an oval-bumin-induced murine model. Mol Immunol 131: 60-67.
20. Li X, Zhou L, Zhang Z, Liu Y, Liu J, Zhang C (2020) IL-27 alleviates airway remodeling in a mouse model of asthma via PI3K/Akt pathway. Exp Lung Res 46: 98-108.
21. Liu L, Li X, Yuan R, Zhang H, Qiang L, Shen J, Jin S (2015) Associations of ABHD2 genetic variations with risks for chronic obstruc-tive pulmonary disease in a Chinese Han population. PLoS One 10: e0123929.
22. Matoba A, Matsuyama N, Shibata S, Masaki E, Emala CW Sr, Mizuta K (2018) The free fatty acid receptor 1 promotes airway smooth muscle cell proliferation through MEK/ERK and PI3K/Akt signaling pathways. Am J Physiol Lung Cell Mol Physiol 314: L333-L348.
23. Mei D, Tan WS, Wong WS (2019) Pharmacological strategies to regain steroid sensitivity in severe asthma and COPD. Curr Opin Pharmacol 46: 73-81.
24. Miricescu D, Balan DG, Tulin A, Stiru O, Vacaroiu IA, Mihai DA, Popa CC, Papacocea RI, Enyedi M, Sorin NA, Vatachki G, Georgescu DE, Nica AE, Stefani C (2021) PI3K/AKT/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis (Re-view). Exp Ther Med 21: 540.
25. Miyata K, Nakayama M, Mizuta S, Hokimoto S, Sugamura K, Oshima S, Oike Y, Sugiyama S, Ogawa H, Yamamura K (2008) Elevated mature macrophage expression of human ABHD2 gene in vulnerable plaque. Biochem Biophys Res Commun 365: 207-213.
26. Morissette M, Godbout K, Cote A, Boulet LP (2022) Asthma COPD overlap: Insights into cellular and molecular mechanisms. Mol As-pects Med 85: 101021.
27. Nakawah MO, Hawkins C, Barbandi F (2013) Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome. J Am Board Fam Med 26: 470-477.
28. Neveu WA, Allard JL, Raymond DM, Bourassa LM, Burns SM, Bunn JY, Irvin CG, Kaminsky DA, Rincon M (2010) Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function. Respir Res 11: 28.
29. Pan J, Yang Q, Zhou Y, Deng H, Zhu Y, Zhao D, Liu F (2020) MicroRNA-221 Modulates Airway Remodeling via the PI3K/AKT Pathway in OVA-Induced Chronic Murine Asthma. Front Cell Dev Biol 8: 495. 30. Revathidevi S, Munirajan AK (2019) Akt in cancer: Mediator and more. Semin Cancer Biol 59: 80-91.
31. Wang Z, Li R, Zhong R (2018) Extracellular matrix promotes proliferation, migration and adhesion of airway smooth muscle cells in a rat model of chronic obstructive pulmonary disease via upregulation of the PI3K/AKT signaling pathway. Mol Med Rep 18: 3143-3152.
32. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, Koth LL, Arron JR, Fahy JV (2009) T-helper type 2-driven in-flammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180: 388-395.
33. Yan F, Hao Y, Gong X, Sun H, Ding J, Wang J (2021) Silencing a disintegrin and metalloproteinase-33 attenuates the proliferation of vascular smooth muscle cells via PI3K/AKT pathway: Implications in the pathogenesis of airway vascular remodeling. Mol Med Rep 24: 502.
Go to article

Authors and Affiliations

L. Qiang
1
X. Li
1
Q. Li
2
H. Bo
3
Y. Liu
1
M. Lv
1
X. Chen
1
H. Ju
1
X. Sang
1
Z. Li
4
S. Jin
1

  1. Department of Respiratory Medicine, Fourth Affiliated Hospital, Harbin Medical University, 37# Yiyuan Street, Harbin 150001, Heilongjiang, China
  2. Department of pulmonary diseases, Heilongjiang Academy of Traditional Chinese Medicine, 33# Xidazhi Street, Harbin 150036, Heilongjiang, China
  3. Department of Intensive Care Unit, Fourth Affiliated Hospital, Harbin Medical University, 37# Yiyuan Street, Harbin 150001, Heilongjiang, China
  4. University of Tokyo, 3-8-1# Bunkyo ku, Tokyo 1130033, Tokyo, Japan

This page uses 'cookies'. Learn more